• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2023 Feb 14;29(3).
doi: 10.3201/eid2903.221297. Online ahead of print.
New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany

Fabian Heinrich, Tobias Huter, Sophie Mertens, Philine Lange, Jessica Vering, Axel Heinemann, Dominik Sebastian Nörz, Armin Hoffmann, Martin Aepfelbacher, Benjamin Ondruschka, Susanne Krasemann, Marc Lütgehetmann

Abstract

We performed autopsies on persons in Germany who died from COVID-19 and observed higher nasopharyngeal SARS-CoV-2 viral loads for variants of concern (VOC) compared with non-VOC lineages. Pulmonary inflammation and damage appeared higher in non-VOC than VOC lineages until adjusted for vaccination status, suggesting COVID-19 vaccination may mitigate pulmonary damage.

Keywords: Alpha variant; B.1.1.529; B.1.1.7; B.1.617.2; COVID-19; Delta variant; Germany; Omicron variant; SARS; SARS-CoV-2; VOC; coronavirus; coronavirus disease; organ tropism; pulmonary damage; respiratory infections; severe acute respiratory syndrome coronavirus 2; variants of concern; viral load; viruses; zoonoses.
 
Back
Top Bottom